Host genetic variation and HIV disease: from mapping to mechanism

Immunogenetics

Volumn 69, Issue 8-9, 2017, Pages 489-498

  Naranbhai, Vivek ^a,b,c   Carrington, Mary ^a,b  

^a FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

CCR5; HIV; HLA; Host genetics; Immunology

Indexed keywords

CHEMOKINE RECEPTOR CCR5; HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR; LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; CCR5 PROTEIN, HUMAN;

ALLELE; DISEASE COURSE; GENE MAPPING; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIATION; HERITABILITY; HLA SYSTEM; HOMOZYGOSITY; HOST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBIOLOGY; IMMUNOGENETICS; INFECTION CONTROL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; VACCINATION; VIRAL GENETICS; VIRUS ENTRY; GENE; GENETICS;

GENES, MHC CLASS I; GENETIC VARIATION; HIV INFECTIONS; HUMANS; IMMUNOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR5; VIRUS INTERNALIZATION;

EID: 85022202636     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/s00251-017-1000-z     Document Type: Review

References (112)

1. Adland E et al (2015) Discordant impact of HLA on viral replicative capacity and disease progression in pediatric and adult HIV infection. PLoS Pathog 11:e1004954
2. Alkhatib G, Locati M, Kennedy PE, Murphy PM, Berger EA (1997) HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation. Virology 234:340
3. Alter G et al (2011) HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 476:96
4. Apps R et al (2013) Influence of HLA-C expression level on HIV control. Science 340:87
5. Bandera A, Colella E, Rizzardini G, Gori A, Clerici M (2017) Strategies to limit immune-activation in HIV patients. Expert Rev Anti-Infect Ther 15:43
6. Bartha I et al (2013) A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control. elife 2:e01123
7. Bartha I et al (2017) Estimating the respective contributions of human and viral genetic variation to HIV control. PLoS Comput Biol 13:e1005339
8. Bashirova AA et al (2014) LILRB2 interaction with HLA class I correlates with control of HIV-1 infection. PLoS Genet 10:e1004196
9. Boily MC et al (2009) Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9:118
10. Brumme ZL et al (2007) Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1. PLoS Pathog 3:e94
11. Burian A et al (2016) HLA-F and MHC-I open conformers bind natural killer cell Ig-like receptor KIR3DS1. PLoS One 11:e0163297
12. Bushman FD et al (May, 2009) Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog 5:e1000437
13. Carlson JM, Brumme ZL (2008) HIV evolution in response to HLA-restricted CTL selection pressures: a population-based perspective. Microbes Infect 10:455
14. Carlson JM et al (2012) Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1. J Virol 86:13202
15. Carlson JM et al (2016) Impact of pre-adapted HIV transmission. Nat Med 22:606
16. Carrington M et al (1999) HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283:1748
17. Chantarangsu S et al (2011) Genome-wide association study identifies variations in 6p21.3 associated with nevirapine-induced rash. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 53:341
18. Choe H et al (1996) The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135
19. Dahirel V et al (2011) Coordinate linkage of HIV evolution reveals regions of immunological vulnerability. Proc Natl Acad Sci U S A 108:11530
20. Dean M et al (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273:1856
21. Deng H et al (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661
22. Didelez V, Sheehan N (2007) Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res 16:309
23. Dolan MJ et al (2007) CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol 8:1324
24. Doranz BJ et al (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149
25. Dragic T et al (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667
26. Fellay J et al (2007) A whole-genome association study of major determinants for host control of HIV-1. Science 317:944
27. Fellay J et al (2009) Common genetic variation and the control of HIV-1 in humans. PLoS Genet 5:e1000791
28. Ferguson AL et al (2013) Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design. Immunity 38:606
29. Ferreira MA et al (2010) Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control. Am J Hum Genet 86:88
30. Flores-Villanueva PO et al (2001) Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci U S A 98:5140
31. Fraser C et al (2014) Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective. Science 343:1243727
32. Galvani AP, Slatkin M (2003) Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta32 HIV-resistance allele. Proc Natl Acad Sci U S A 100:15276
33. Gao X et al (2005) AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med 11:1290
34. Garcia-Beltran WF et al (2016) Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1. Nat Immunol 17:1067
35. Gonzalez E et al (2005) The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 307:1434
36. H. I. V. C. S. International et al (2010) The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330:1551
37. van der Helm JJ et al (2014) Characterisation of long-term non-progression of HIV-1 infection after seroconversion: a cohort study. The lancet HIV 1:e41
38. Herbeck JT et al (2010) Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. The Journal of infectious diseases 201:618
39. Herbeck JT et al (2012) Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission. AIDS 26:193
40. Holzemer A et al (2015) Selection of an HLA-C*03:04-restricted HIV-1 p24 gag sequence variant is associated with viral escape from KIR2DL3+ natural killer cells: data from an observational cohort in South Africa. PLoS Med 12:e1001900; discussion e1001900
41. Horowitz A et al (2016) Class I HLA haplotypes form two schools that educate NK cells in different ways. Science Immunology 1:eaag1672
42. Huang J et al (2009) HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses. J Exp Med 206:2959
43. Hummel S, Schmidt D, Kremeyer B, Herrmann B, Oppermann M (2005) Detection of the CCR5-Delta32 HIV resistance gene in Bronze Age skeletons. Genes Immun 6:371
44. Hutter G et al (2009) Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 360:692
45. Irvin MR et al (2011) Genes linked to energy metabolism and immunoregulatory mechanisms are associated with subcutaneous adipose tissue distribution in HIV-infected men. Pharmacogenet Genomics 21:798
46. Johnson EO et al (2015) Novel genetic locus implicated for HIV-1 acquisition with putative regulatory links to HIV replication and infectivity: a genome-wide association study. PLoS One 10:e0118149
47. Jones DC et al (2011) HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. J Immunol 186:2990
48. Joubert BR et al (2010) A whole genome association study of mother-to-child transmission of HIV in Malawi. Genome medicine 2:17
49. Juarez-Molina CI et al (2014) Impact of HLA selection pressure on HIV fitness at a population level in Mexico and Barbados. J Virol 88:10392
50. Julg B et al (2011) Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection. The Journal of infectious diseases 203:803
51. Kawashima Y et al (2009) Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458:641
52. Kroner BL et al (1995) Concordance of human leukocyte antigen haplotype-sharing, CD4 decline and AIDS in hemophilic siblings. Multicenter Hemophilia Cohort and Hemophilia Growth and Development Studies. AIDS 9:275
53. Kulkarni S et al (2011) Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472:495
54. Kulkarni S et al (2013) Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease. Proc Natl Acad Sci U S A 110:20705
55. Lander ES et al (2001) Initial sequencing and analysis of the human genome. Nature 409:860
56. Le Clerc S et al (2009) Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03). The Journal of infectious diseases 200:1194
57. Leger PD et al (2014) Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group Protocol 384. J Neurovirol 20:304
58. Lehmann DS et al (2015) Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols. Pharmacogenet Genomics 25:51
59. Levine AJ et al (2012) Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults. American Journal of Medical Genetics. Part B. Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 159B:669
60. Limou S et al (2009) Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). The Journal of Infectious Diseases 199:419
61. Lingappa JR et al (2011) Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure. PLoS One 6:e28632
62. Liu R et al (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367
63. Lucotte G, Mercier G (1998) Distribution of the CCR5 gene 32-bp deletion in Europe. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 19:174
64. MacDonald KS et al (1998) Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. The Journal of infectious diseases 177:551
65. Mackelprang RD et al (2008) Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1. The Journal of Infectious Diseases 197:1156
66. Martin MP, Carrington M (2013) Immunogenetics of HIV disease. Immunol Rev 254:245
67. Martin MP et al (1998) Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 282:1907
68. Martin MP et al (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31:429
69. Martin MP et al (2007) Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 39:733
70. Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB (1997) Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 16:100
71. Matzaraki V, Kumar V, Wijmenga C, Zhernakova A (2017) The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol 18:76
72. McDermott DH et al (1998) CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet 352:866
73. McLaren PJ, Carrington M (2015) The impact of host genetic variation on infection with HIV-1. Nat Immunol 16:577
74. McLaren PJ et al (2013) Association study of common genetic variants and HIV-1 acquisition in 6300 infected cases and 7200 controls. PLoS Pathog 9:e1003515
75. McLaren PJ et al (2015) Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load. Proc Natl Acad Sci U S A 112:14658
76. Merino AM et al (2013) Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells. Clin Exp Immunol 174:414
77. Misrahi M et al (1998) CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group. JAMA 279:277
78. Mlisana K et al (2014) Rapid disease progression in HIV-1 subtype C-infected South African women. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 59:1322
79. Moore CB et al (2015) Phenome-wide association study relating pretreatment laboratory parameters with human genetic variants in AIDS Clinical Trials Group protocols. Open forum infectious diseases 2:ofu113
80. Mummidi S et al (1998) Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med 4:786
81. Nixon DF et al (1988) HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336:484
82. Norman PJ et al (2016) Defining KIR and HLA class I genotypes at highest resolution via high-throughput sequencing. Am J Hum Genet 99:375
83. Novembre J, Galvani AP, Slatkin M (2005) The geographic spread of the CCR5 Delta32 HIV-resistance allele. PLoS Biol 3:e339
84. O'Connor GM et al (2015) Peptide-dependent recognition of HLA-B*57:01 by KIR3DS1. J Virol 89:5213
85. Park RJ et al (2017) A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors. Nat Genet 49:193
86. Payne R et al (2014) Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence. Proc Natl Acad Sci U S A 111:E5393
87. Pelak K et al (2010) Host determinants of HIV-1 control in African Americans. The Journal of Infectious Diseases 201:1141
88. K. Pelak, Shianna, K., Ge, D., and Goldstein, D, Paper presented at the The American Society of Human Genetics (ASHG), Montreal., 2011
89. Petrovski S et al (2011) Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population. AIDS 25:513
90. Polycarpou A et al (2002) Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type 1 transmission. AIDS Res Hum Retrovir 18:741
91. Ramsuran V et al (2011) Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black women. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 52:1248
92. Ramsuran V et al (2015) Epigenetic regulation of differential HLA-A allelic expression levels. Hum Mol Genet 24:4268
93. Ramsuran V et al (2017) Sequence and phylogenetic analysis of the untranslated promoter regions for HLA class I genes. J Immunol 198:2320
94. Ranasinghe S et al (2013) Association of HLA-DRB1-restricted CD4(+) T cell responses with HIV immune control. Nat Med 19:930
95. Rucker J et al (1996) Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87:437
96. Sabeti PC et al (2005) The case for selection at CCR5-Delta32. PLoS Biol 3:e378
97. Samson M et al (1996) Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722
98. Sereti I, Altfeld M (2016) Immune activation and HIV: an enduring relationship. Curr Opin HIV AIDS 11:129
99. Shrestha S et al (2010) A genome-wide association study of carotid atherosclerosis in HIV-infected men. AIDS 24:583
100. Smith MW et al (1997) Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277:959
101. Stephens JC et al (1998) Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet 62:1507
102. Tang J et al (1999) HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. AIDS Res Hum Retrovir 15:317
103. Tebas P et al (2014) Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med 370:901
104. Thomas R et al (2009) HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet 41:1290
105. Troyer JL et al (2011) Genome-wide association study implicates PARD3B-based AIDS restriction. The Journal of infectious diseases 203:1491
106. Ulveling D et al (2016) A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients. Hepatology 64:1462
107. Vince N et al (2016) HLA-C level is regulated by a polymorphic Oct1 binding site in the HLA-C promoter region. Am J Hum Genet 99:1353
108. Voight BF et al (2012) Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. Lancet 380:572
109. Walker BD et al (1987) HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:345
110. Wei Z et al (2015) Genome-wide association studies of HIV-1 host control in ethnically diverse Chinese populations. Scientific reports 5:10879
111. Zhu J et al (2014) Comprehensive identification of host modulators of HIV-1 replication using multiple orthologous RNAi reagents. Cell Rep 9:752
112. Zinkernagel RM, Doherty PC (1974) Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248:701